WeLeader Biomedical Co., Ltd. (TPEX:7713)

Taiwan · Delayed Price · Currency is TWD

71.80

-1.00 (-1.37%)

Sep 5, 2025, 1:17 PM CST

WeLeader Biomedical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,022	991.13	940.7	1,036	841.14
Revenue Growth (YoY)	5.74%	5.36%	-9.17%	23.13%	-
Cost of Revenue	698.04	674.8	642.62	743.97	622.22
Gross Profit	323.63	316.32	298.08	291.75	218.92
Selling, General & Admin	105.9	102.13	100.59	97.64	86.26
Operating Expenses	105.75	102.19	100.12	97.11	86.65
Operating Income	217.88	214.14	197.96	194.64	132.28
Interest Expense	-6.03	-5.8	-5.69	-4.21	-6.16
Interest & Investment Income	2.15	1.29	0.59	0.24	0.08
Other Non Operating Income (Expenses)	4.86	5.2	2.27	1.88	4.85
EBT Excluding Unusual Items	218.86	214.83	195.13	192.54	131.04
Gain (Loss) on Sale of Investments	0.16	0.4	0.1	-0.68	0.01
Gain (Loss) on Sale of Assets	-	-0.02	-1.69	0.69	0.41
Pretax Income	219.02	215.21	193.55	192.55	131.46
Income Tax Expense	43.76	44.99	41.26	38.75	25.69
Net Income	175.26	170.21	152.28	153.8	105.77
Net Income to Common	175.26	170.21	152.28	153.8	105.77
Net Income Growth	7.44%	11.77%	-0.98%	45.40%	-
Shares Outstanding (Basic)	43	42	41	30	28
Shares Outstanding (Diluted)	43	42	41	30	28
Shares Change (YoY)	3.69%	1.55%	35.00%	8.28%	-
EPS (Basic)	4.08	4.09	3.74	5.13	3.79
EPS (Diluted)	4.06	4.08	3.71	5.05	3.76
EPS Growth	3.58%	9.97%	-26.53%	34.31%	-
Free Cash Flow	145.04	108.06	117.13	-379.09	216.43
Free Cash Flow Per Share	3.36	2.59	2.85	-12.46	7.70
Dividend Per Share	3.368	3.368	2.300	0.860	0.450
Dividend Growth	46.43%	46.43%	167.44%	91.11%	-
Gross Margin	31.68%	31.92%	31.69%	28.17%	26.03%
Operating Margin	21.33%	21.61%	21.04%	18.79%	15.73%
Profit Margin	17.15%	17.17%	16.19%	14.85%	12.57%
Free Cash Flow Margin	14.20%	10.90%	12.45%	-36.60%	25.73%
EBITDA	246.95	242.96	227.58	226.65	165.64
EBITDA Margin	24.17%	24.51%	24.19%	21.88%	19.69%
D&A For EBITDA	29.07	28.83	29.62	32.01	33.36
EBIT	217.88	214.14	197.96	194.64	132.28
EBIT Margin	21.33%	21.61%	21.04%	18.79%	15.73%
Effective Tax Rate	19.98%	20.91%	21.32%	20.13%	19.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.